Day: December 11, 2023

LambdaTest and Wipro Collaborate for Innovative Gen AI Solutions

LambdaTest and Wipro forge a pioneering partnership, integrating Wipro’s Gen AI-powered QE capabilities with LambdaTest’s HyperExecute, to revolutionize software testing on the Cloud with advanced AI capabilities. San Francisco , Dec. 11, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform is partnering with Wipro Limited, a leading technology services and consulting company, to revolutionize […]

Continue Reading »

Pangea Releases Annual Report + Advanced Products

Leather Supplier Lowers Emissions: Now and in the Future ROCHESTER HILLS, Mich., Dec. 11, 2023 (GLOBE NEWSWIRE) — Pangea, automotive leather supplier, announces the launch of their second sustainability report, key progress, and a line of advanced products. The company is committed to transparent disclosure of Corporate Social Responsibility (CSR) activities. This includes accelerating manufacturing sustainability […]

Continue Reading »

Meet Fortinet Advisor, a Generative AI Assistant that Accelerates Threat Investigation and Remediation

Fortinet harnesses more than a decade of AI innovation and deep threat expertise to empower customers with a cutting-edge GenAI tool that upskills cybersecurity teams SUNNYVALE, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today added Fortinet Advisor, a generative AI (GenAI) […]

Continue Reading »

BASF Environmental Catalyst and Metal Solutions (ECMS) signs agreement to acquire Arc Metal AB in Sweden

Acquisition adds smelting capability to serve spent automotive catalyst customers in Europe, Middle East and Africa Complements ECMS recycling operations and global precious metal services Broadens range of materials that can be processed by ECMS Closing of transaction expected in early first quarter 2024 ISELIN, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — BASF Environmental Catalyst […]

Continue Reading »

Duck Creek Technologies Appoints Barbara Bufkin and Diane Fanelli to Board of Directors

Accomplished executives bring decades of insurance and technology expertise to new board roles Barbara Bufkin BOSTON, Dec. 11, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointments of Barbara Bufkin and Diane Fanelli to the company’s board of […]

Continue Reading »

Acronis Visionary Approach to Cybersecurity for MSPs Highlighted in Frost Radar™: Endpoint Security, 2023

Recognition shows why MSPs consider Acronis a best-of-breed solution for modern cybersecurity Acronis Visionary Approach to Cybersecurity Highlighted in Frost Radar™: Endpoint Security, 2023 BURLINGTON, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, has been highlighted in Frost & Sullivan’s Frost Radar report for Endpoint Security as one of […]

Continue Reading »

Acronis Visionary Approach to Cybersecurity for MSPs Highlighted in Frost Radar™: Endpoint Security, 2023

Recognition shows why MSPs consider Acronis a best-of-breed solution for modern cybersecurity Acronis Visionary Approach to Cybersecurity Highlighted in Frost Radar™: Endpoint Security, 2023 BURLINGTON, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, has been highlighted in Frost & Sullivan’s Frost Radar report for Endpoint Security as one of […]

Continue Reading »

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer

Novel Non-surgical Intradermal Treatment for Basel Cell Carcinoma COSA MESA, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — AiViva Biopharma Inc., a clinical-stage biotechnology company, announced completion of their first trial administering AIV001 (axitinib) to patients diagnosed with basal cell carcinoma (BCC) tumors. AIV001 is AiViva’s novel intradermally administered product designed for local, prolonged treatment effect […]

Continue Reading »